Characterization of the dizocilpine binding site on the nicotinic acetylcholine receptor

Autores
Arias, Hugo Rubén; Mccardy, Elizabeth A.; Blanton, Michael P.
Año de publicación
2001
Idioma
inglés
Tipo de recurso
artículo
Estado
versión publicada
Descripción
Although the dissociative anesthetic dizocilpine [(+)-MK-801] inhibits nicotinic acetylcholine receptor (AChR) function in a noncompetitive manner, the location of the dizocilpine binding site(s) has yet to be clearly established. Thus, to characterize the binding site for dizocilpine on the AChR we examined 1) the dissociation constant (Kd) and stoichiometry of [3H]dizocilpine binding; 2) the displacement of dizocilpine radioligand binding by noncompetitive inhibitors (NCIs) and conversely dizocilpine displacement of fluorescent and radiolabeled NCIs from their respective high-affinity binding sites on the AChR; and 3) photoaffinity labeling of the AChR using 125I-dizocilpine. The results establish that one high-affinity (Kd = 4.8 μM) and several (3-6) low-affinity (Kd = ∼ 140 μM) binding sites exist for dizocilpine on the desensitized and resting AChR, respectively. The binding of the fluorescent NCIs ethidium, quinacrine, and crystal violet as well as [3H]thienylcyclohexylpiperidine was inhibited by dizocilpine on desensitized AChRs. However, Schild-type analyses indicate that only the inhibition of quinacrine in the desensitized state seems to be mediated by a mutually exclusive action. Photoaffinity labeling of the AChR by 125I-dizocilpine was primarily restricted to the α1 subunit and subsequent mapping revealed that the principal sites of labeling are localized to the M4 (∼70%) and M1 (30%) transmembrane domains. Collectively, the data indicate that the high-affinity dizocilpine binding site is not located in the lumen of the ion channel but probably near the quinacrine binding locus at a nonluminal domain in the AChR desensitized state.
Fil: Arias, Hugo Rubén. Texas Tech University. Health Sciences Center; Estados Unidos. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina
Fil: Mccardy, Elizabeth A.. Texas Tech University. Health Sciences Center; Estados Unidos
Fil: Blanton, Michael P.. Texas Tech University. Health Sciences Center; Estados Unidos
Materia
Nicotinic Acetylcholine Receptor
Dizoclipine
Photoaffinity Labeling
Radioligand Binding
Nivel de accesibilidad
acceso abierto
Condiciones de uso
https://creativecommons.org/licenses/by-nc-sa/2.5/ar/
Repositorio
CONICET Digital (CONICET)
Institución
Consejo Nacional de Investigaciones Científicas y Técnicas
OAI Identificador
oai:ri.conicet.gov.ar:11336/78744

id CONICETDig_f4aa92b7bf1cce78f03840f88d282f22
oai_identifier_str oai:ri.conicet.gov.ar:11336/78744
network_acronym_str CONICETDig
repository_id_str 3498
network_name_str CONICET Digital (CONICET)
spelling Characterization of the dizocilpine binding site on the nicotinic acetylcholine receptorArias, Hugo RubénMccardy, Elizabeth A.Blanton, Michael P.Nicotinic Acetylcholine ReceptorDizoclipinePhotoaffinity LabelingRadioligand Bindinghttps://purl.org/becyt/ford/3.1https://purl.org/becyt/ford/3Although the dissociative anesthetic dizocilpine [(+)-MK-801] inhibits nicotinic acetylcholine receptor (AChR) function in a noncompetitive manner, the location of the dizocilpine binding site(s) has yet to be clearly established. Thus, to characterize the binding site for dizocilpine on the AChR we examined 1) the dissociation constant (Kd) and stoichiometry of [3H]dizocilpine binding; 2) the displacement of dizocilpine radioligand binding by noncompetitive inhibitors (NCIs) and conversely dizocilpine displacement of fluorescent and radiolabeled NCIs from their respective high-affinity binding sites on the AChR; and 3) photoaffinity labeling of the AChR using 125I-dizocilpine. The results establish that one high-affinity (Kd = 4.8 μM) and several (3-6) low-affinity (Kd = ∼ 140 μM) binding sites exist for dizocilpine on the desensitized and resting AChR, respectively. The binding of the fluorescent NCIs ethidium, quinacrine, and crystal violet as well as [3H]thienylcyclohexylpiperidine was inhibited by dizocilpine on desensitized AChRs. However, Schild-type analyses indicate that only the inhibition of quinacrine in the desensitized state seems to be mediated by a mutually exclusive action. Photoaffinity labeling of the AChR by 125I-dizocilpine was primarily restricted to the α1 subunit and subsequent mapping revealed that the principal sites of labeling are localized to the M4 (∼70%) and M1 (30%) transmembrane domains. Collectively, the data indicate that the high-affinity dizocilpine binding site is not located in the lumen of the ion channel but probably near the quinacrine binding locus at a nonluminal domain in the AChR desensitized state.Fil: Arias, Hugo Rubén. Texas Tech University. Health Sciences Center; Estados Unidos. Consejo Nacional de Investigaciones Científicas y Técnicas; ArgentinaFil: Mccardy, Elizabeth A.. Texas Tech University. Health Sciences Center; Estados UnidosFil: Blanton, Michael P.. Texas Tech University. Health Sciences Center; Estados UnidosAmerican Society for Pharmacology and Experimental Therapeutics2001-05info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionhttp://purl.org/coar/resource_type/c_6501info:ar-repo/semantics/articuloapplication/pdfapplication/pdfhttp://hdl.handle.net/11336/78744Arias, Hugo Rubén; Mccardy, Elizabeth A.; Blanton, Michael P.; Characterization of the dizocilpine binding site on the nicotinic acetylcholine receptor; American Society for Pharmacology and Experimental Therapeutics; Molecular Pharmacology; 59; 5; 5-2001; 1051-10600026-895X1521-0111CONICET DigitalCONICETenginfo:eu-repo/semantics/altIdentifier/url/http://molpharm.aspetjournals.org/content/59/5/1051info:eu-repo/semantics/altIdentifier/doi/10.1124/mol.59.5.1051info:eu-repo/semantics/openAccesshttps://creativecommons.org/licenses/by-nc-sa/2.5/ar/reponame:CONICET Digital (CONICET)instname:Consejo Nacional de Investigaciones Científicas y Técnicas2025-09-10T13:02:12Zoai:ri.conicet.gov.ar:11336/78744instacron:CONICETInstitucionalhttp://ri.conicet.gov.ar/Organismo científico-tecnológicoNo correspondehttp://ri.conicet.gov.ar/oai/requestdasensio@conicet.gov.ar; lcarlino@conicet.gov.arArgentinaNo correspondeNo correspondeNo correspondeopendoar:34982025-09-10 13:02:12.46CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicasfalse
dc.title.none.fl_str_mv Characterization of the dizocilpine binding site on the nicotinic acetylcholine receptor
title Characterization of the dizocilpine binding site on the nicotinic acetylcholine receptor
spellingShingle Characterization of the dizocilpine binding site on the nicotinic acetylcholine receptor
Arias, Hugo Rubén
Nicotinic Acetylcholine Receptor
Dizoclipine
Photoaffinity Labeling
Radioligand Binding
title_short Characterization of the dizocilpine binding site on the nicotinic acetylcholine receptor
title_full Characterization of the dizocilpine binding site on the nicotinic acetylcholine receptor
title_fullStr Characterization of the dizocilpine binding site on the nicotinic acetylcholine receptor
title_full_unstemmed Characterization of the dizocilpine binding site on the nicotinic acetylcholine receptor
title_sort Characterization of the dizocilpine binding site on the nicotinic acetylcholine receptor
dc.creator.none.fl_str_mv Arias, Hugo Rubén
Mccardy, Elizabeth A.
Blanton, Michael P.
author Arias, Hugo Rubén
author_facet Arias, Hugo Rubén
Mccardy, Elizabeth A.
Blanton, Michael P.
author_role author
author2 Mccardy, Elizabeth A.
Blanton, Michael P.
author2_role author
author
dc.subject.none.fl_str_mv Nicotinic Acetylcholine Receptor
Dizoclipine
Photoaffinity Labeling
Radioligand Binding
topic Nicotinic Acetylcholine Receptor
Dizoclipine
Photoaffinity Labeling
Radioligand Binding
purl_subject.fl_str_mv https://purl.org/becyt/ford/3.1
https://purl.org/becyt/ford/3
dc.description.none.fl_txt_mv Although the dissociative anesthetic dizocilpine [(+)-MK-801] inhibits nicotinic acetylcholine receptor (AChR) function in a noncompetitive manner, the location of the dizocilpine binding site(s) has yet to be clearly established. Thus, to characterize the binding site for dizocilpine on the AChR we examined 1) the dissociation constant (Kd) and stoichiometry of [3H]dizocilpine binding; 2) the displacement of dizocilpine radioligand binding by noncompetitive inhibitors (NCIs) and conversely dizocilpine displacement of fluorescent and radiolabeled NCIs from their respective high-affinity binding sites on the AChR; and 3) photoaffinity labeling of the AChR using 125I-dizocilpine. The results establish that one high-affinity (Kd = 4.8 μM) and several (3-6) low-affinity (Kd = ∼ 140 μM) binding sites exist for dizocilpine on the desensitized and resting AChR, respectively. The binding of the fluorescent NCIs ethidium, quinacrine, and crystal violet as well as [3H]thienylcyclohexylpiperidine was inhibited by dizocilpine on desensitized AChRs. However, Schild-type analyses indicate that only the inhibition of quinacrine in the desensitized state seems to be mediated by a mutually exclusive action. Photoaffinity labeling of the AChR by 125I-dizocilpine was primarily restricted to the α1 subunit and subsequent mapping revealed that the principal sites of labeling are localized to the M4 (∼70%) and M1 (30%) transmembrane domains. Collectively, the data indicate that the high-affinity dizocilpine binding site is not located in the lumen of the ion channel but probably near the quinacrine binding locus at a nonluminal domain in the AChR desensitized state.
Fil: Arias, Hugo Rubén. Texas Tech University. Health Sciences Center; Estados Unidos. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina
Fil: Mccardy, Elizabeth A.. Texas Tech University. Health Sciences Center; Estados Unidos
Fil: Blanton, Michael P.. Texas Tech University. Health Sciences Center; Estados Unidos
description Although the dissociative anesthetic dizocilpine [(+)-MK-801] inhibits nicotinic acetylcholine receptor (AChR) function in a noncompetitive manner, the location of the dizocilpine binding site(s) has yet to be clearly established. Thus, to characterize the binding site for dizocilpine on the AChR we examined 1) the dissociation constant (Kd) and stoichiometry of [3H]dizocilpine binding; 2) the displacement of dizocilpine radioligand binding by noncompetitive inhibitors (NCIs) and conversely dizocilpine displacement of fluorescent and radiolabeled NCIs from their respective high-affinity binding sites on the AChR; and 3) photoaffinity labeling of the AChR using 125I-dizocilpine. The results establish that one high-affinity (Kd = 4.8 μM) and several (3-6) low-affinity (Kd = ∼ 140 μM) binding sites exist for dizocilpine on the desensitized and resting AChR, respectively. The binding of the fluorescent NCIs ethidium, quinacrine, and crystal violet as well as [3H]thienylcyclohexylpiperidine was inhibited by dizocilpine on desensitized AChRs. However, Schild-type analyses indicate that only the inhibition of quinacrine in the desensitized state seems to be mediated by a mutually exclusive action. Photoaffinity labeling of the AChR by 125I-dizocilpine was primarily restricted to the α1 subunit and subsequent mapping revealed that the principal sites of labeling are localized to the M4 (∼70%) and M1 (30%) transmembrane domains. Collectively, the data indicate that the high-affinity dizocilpine binding site is not located in the lumen of the ion channel but probably near the quinacrine binding locus at a nonluminal domain in the AChR desensitized state.
publishDate 2001
dc.date.none.fl_str_mv 2001-05
dc.type.none.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
http://purl.org/coar/resource_type/c_6501
info:ar-repo/semantics/articulo
format article
status_str publishedVersion
dc.identifier.none.fl_str_mv http://hdl.handle.net/11336/78744
Arias, Hugo Rubén; Mccardy, Elizabeth A.; Blanton, Michael P.; Characterization of the dizocilpine binding site on the nicotinic acetylcholine receptor; American Society for Pharmacology and Experimental Therapeutics; Molecular Pharmacology; 59; 5; 5-2001; 1051-1060
0026-895X
1521-0111
CONICET Digital
CONICET
url http://hdl.handle.net/11336/78744
identifier_str_mv Arias, Hugo Rubén; Mccardy, Elizabeth A.; Blanton, Michael P.; Characterization of the dizocilpine binding site on the nicotinic acetylcholine receptor; American Society for Pharmacology and Experimental Therapeutics; Molecular Pharmacology; 59; 5; 5-2001; 1051-1060
0026-895X
1521-0111
CONICET Digital
CONICET
dc.language.none.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv info:eu-repo/semantics/altIdentifier/url/http://molpharm.aspetjournals.org/content/59/5/1051
info:eu-repo/semantics/altIdentifier/doi/10.1124/mol.59.5.1051
dc.rights.none.fl_str_mv info:eu-repo/semantics/openAccess
https://creativecommons.org/licenses/by-nc-sa/2.5/ar/
eu_rights_str_mv openAccess
rights_invalid_str_mv https://creativecommons.org/licenses/by-nc-sa/2.5/ar/
dc.format.none.fl_str_mv application/pdf
application/pdf
dc.publisher.none.fl_str_mv American Society for Pharmacology and Experimental Therapeutics
publisher.none.fl_str_mv American Society for Pharmacology and Experimental Therapeutics
dc.source.none.fl_str_mv reponame:CONICET Digital (CONICET)
instname:Consejo Nacional de Investigaciones Científicas y Técnicas
reponame_str CONICET Digital (CONICET)
collection CONICET Digital (CONICET)
instname_str Consejo Nacional de Investigaciones Científicas y Técnicas
repository.name.fl_str_mv CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicas
repository.mail.fl_str_mv dasensio@conicet.gov.ar; lcarlino@conicet.gov.ar
_version_ 1842980001097449472
score 13.004268